Simultaneous Detection of Tumor Derived Exosomal Protein–MicroRNA Pairs with an Exo-PROS Biosensor for Cancer Diagnosis

Chang-Chieh Hsu, Yunchen Yang, Eric Kannisto, Xie Zeng, Guan Yu, Santosh K. Patnaik, Grace K. Dy, Mary E. Reid, Qiaoqiang Gan, Yun Wu

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Tumor derived exosomes (TEXs) have emerged as promising biomarkers for cancer liquid biopsy. Conventional methods (such as ELISA and qRT-PCR) and emerging biosensing technologies mainly detect a single type of exosomal biomarker due to the distinct properties of different biomolecules. Sensitive detection of two different types of TEX biomarkers, i.e., protein and microRNA combined biomarkers, may greatly improve cancer diagnostic accuracy. We developed an exosome protein microRNA one-stop (Exo-PROS) biosensor that not only selectively captured TEXs but also enabled in situ, simultaneous detection of TEX protein–microRNA pairs via a surface plasmon resonance mechanism. Exo-PROS assay is a fast, reliable, low sample consumption, and user-friendly test. With a total of 175 cancer patients and normal controls, we demonstrated that TEX protein–microRNA pairs measured by Exo-PROS assay detected lung cancer and breast cancer with 99% and 96% accuracy, respectively. Exo-PROS assay also showed superior diagnostic performance to conventional ELISA and qRT-PCR methods. Our results demonstrated that Exo-PROS assay is a potent liquid biopsy assay for cancer diagnosis.
Original languageEnglish (US)
JournalACS Nano
DOIs
StatePublished - Apr 27 2023

ASJC Scopus subject areas

  • General Physics and Astronomy
  • General Materials Science
  • General Engineering

Fingerprint

Dive into the research topics of 'Simultaneous Detection of Tumor Derived Exosomal Protein–MicroRNA Pairs with an Exo-PROS Biosensor for Cancer Diagnosis'. Together they form a unique fingerprint.

Cite this